India has always been a hot destination to conduct clinical trials. Many key factors of doing clinical research in India, make it a worthy place.
It’s very logical for sponsors who are interested in selling their products to India’s 1.25 billion population, where demand for new medicines is increasing considerably. Approximately 17% of the world’s population and 20% of the global disease burden is in India.
There is an opportunity to recruit from a huge patient pool who may be eager to participate in trials that would give them access to life saving drugs. Availability of infrastructure and skilled young manpower, English speaking and trained talent pool to manage clinical trials, and all this at a lower cost. In recent time the licensing authority of India (CDSCO) has taken steps to fast track approvals for clinical trials and has also given more freedom and responsibilities to Ethics Committees.
These key factors to conduct clinical trials in India give sponsors an opportunity of a competitive advantage of cost effective trials with access to huge patient population, expertise and ready infrastructure.
Contract Research Organization or Clinical Research Organization in India (CRO) in India
The clinical trial industry is continuously undergoing a positive growth in India. At ProRelix Research we are a goal driven niche Global CRO, passionate about delivering clinical study solutions to meet your needs. At every step we provide expert professional support in order to meet your clinical trials objectives. We recognise that you need experienced, highly motivated, flexible specialists who are able to perform all tasks no matter how big or small. We have the operational flexibility to provide drug development services on a stand-alone basis or as part of an integrated full service solution.
Various services that are being offered for global clients:
– Clinical operations
– Clinical data management & Stat Analysis
– Medical writing
The therapeutic expertise includes:
– Cardiovascular Disease
– Central Nervous System
– Respiratory Diseases
– Infectious Diseases
Mr. Niranjan Andhalkar
Director- Business Development & Client Relations